Ç÷°ü Çö¹Ì°æ ½ÃÀåÀº CAGR 3.72%¸¦ ³ªÅ¸³» 2025³â 2¾ï 13¸¸ 8,000´Þ·¯¿¡¼ 2030³â¿¡´Â 2¾ï 4,020¸¸ 9,000´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ Ç÷°ü Çö¹Ì°æ ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü »ó½Â°ú ³ëÈ·Î ÀÎÇØ Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. Ç÷°ü ³»ºÎ °Ë»ç¿¡ »ç¿ëµÇ´Â ¾ÈÁö¿À½ºÄÚÇÁ´Â Ç÷°ü ÀÌ»ó, Ç÷Àü Á¶¼º, Á×»ó µ¿¸Æ °æÈÁõÀÇ º´±â ºÐ·ù¸¦ Á÷Á¢ ½Ã°¢È ÇÒ ¼ö ÀÖ½À´Ï´Ù. Ç÷°ü Á¶¿µ °Ë»ç¿Í ´Þ¸® Ç÷°ü Çö¹Ì°æ °Ë»ç´Â ħ½ÀÀûÀÌÁö¸¸ Ç÷°ü Áúȯ, ƯÈ÷ ½ÉÇ÷°ü ÁúȯÀÇ Áø´Ü ¹× Ä¡·á¿¡ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ ¼³¸íÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ÇöÀå¿¡¼ ¿ìȸ °úÁ¤À» Áö¿øÇϰí ÃÖÀûÀÇ Ä¡·á Àü·«À» ¾Ë¸®°í ȯÀÚÀÇ °á°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ½ÉÀå ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ³·Àº ħ½À Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½ºÅÙÆ® ¼ö¼ú Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¼¼°è Àα¸ÀÇ ³ë·ÉÈ´Â ¾ÈÁö¿À½ºÄÚÇÁ¿Í °°Àº °í±Þ Áø´Ü µµ±¸ÀÇ Çʿ伺À» ´õ¿í ³ô¿©ÁÝ´Ï´Ù. ºñħ½ÀÀûÀ̰í ȯÀÚ Ä£ÈÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ »ê¾÷ ÁøÃâ±â¾÷ °£ÀÇ Àü·«Àû Á¦ÈÞ°¡ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ACIST Medical Systems, Inc.¿Í Medis Medical Imaging°ú °°Àº ±â¾÷°£ÀÇ Á¦ÈÞ´Â ºÏ¹Ì ½ÃÀå µµ´Þ ¹üÀ§¿Í ±â¼ú Çõ½ÅÀ» °ÈÇÏ°í ¾ÈÁö¿À½ºÄÚÇÁ ±â¼úÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼¼ºÐÈ ºÐ¼®
Ç÷°ü Çö¹Ì°æ ½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°·Î ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â º´¿ø, ¿Ü·¡ ¼¾ÅÍ, ¿¬±¸½Ã¼³ÀÌ Æ÷ÇԵ˴ϴÙ. ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÏ°í ½ÉÇ÷°ü Áúȯ¿¡ ´ëóÇϱâ À§ÇÑ Áøº¸µÈ ÀÇ·á±â±â¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö¸é¼ º´¿øÀÌ ´ëºÎºÐÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. °Ç° °ü¸® ½Ã¼³ °³¼±À» À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÇÇØ Áö¿øµÇ´Â ¼¼°è º´¿ø °Ç¼³ Áõ°¡´Â Ç÷°ü Çö¹Ì°æ ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ¿Ü·¡¼¾Å͵µ ħ½ÀÁ¶Ä¡°¡ º¸±ÞµÊ¿¡ µû¶ó °ßÀηÂÀÌ Áõ°¡Çϰí ÀÖ´Â ÇÑÆí, ¿¬±¸½Ã¼³Àº Ç÷°ü¿¬±¸¸¦ À§ÇÑ ÀÚ±Ý Áõ°¡ÀÇ ÇýÅÃÀ» ¹Þ°í ÀÖ½À´Ï´Ù.
±â¼ú Áøº¸ ¹× Á¶»ç
¿¬±¸°³¹ß ÅõÀÚ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¾ÈÁö¿À½ºÄÚÇÁ ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î Áø´Ü Á¤È®µµ°¡ Çâ»óµÇ°í ¿ëµµ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. X¼± ÃÔ¿µ°ú Ç÷°ü ¿¬±¸¿¡ ´ëÇÑ ÁöÃâ Áõ°¡´Â ¿¬±¸ÀÚ°¡ ½ÉÇ÷°ü°èÀÇ »óŸ¦ Áø´ÜÇÏ°í °ü¸®ÇÏ´Â »õ·Î¿î ¹æ¹ýÀ» ¸ð»öÇϰí Àֱ⠶§¹®¿¡ Çõ½ÅÀûÀÎ ¾ÈÁö¿À ³»½Ã°æ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
Áö¸®Àû Àü¸Á
ºÏ¹Ì´Â ½ÉÇ÷°ü ÁúȯÀÇ ³ôÀº À¯º´·ü°ú °ß°íÇÑ ÇコÄɾî ÀÎÇÁ¶ó¿¡ °ßÀεǾî Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2023³â ij³ª´Ù°¡ Canadian Heart Function Alliance¸¦ Áö¿øÇϱâ À§ÇØ 500¸¸ ´Þ·¯¸¦ ÅõÀÚÇÏ´Â µî Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê´Â ½ÉºÎÀü Áø´Ü ¹× Ä¡·á¸¦ °ÈÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ¿© ¾ÈÁö¿À½ºÄÚÇÁ ¼ö¿ä¸¦ ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áß±¹°ú Àεµ¿Í °°Àº Àα¸°¡ ¸¹Àº ±¹°¡¿¡¼ °Ç° °ü¸® ÅõÀÚ Áõ°¡¿Í ½ÉÇ÷°ü Áúȯ·üÀÇ »ó½Â¿¡ ÈûÀÔ¾î ±Þ¼ÓÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´Àº ¶ÇÇÑ Ã·´Ü ÀÇ·á ¿¬±¸¿Í ÀÎÇÁ¶ó °³¹ß¿¡ ÈûÀÔ¾î Å« ÀáÀç·ÂÀ» º¸¿©ÁÝ´Ï´Ù.
½ÃÀå Àü¸Á
Ç÷°ü Çö¹Ì°æ ½ÃÀåÀº ±â¼ú Áøº¸, Àü·«Àû Á¦ÈÞ, °Ç° °ü¸® ÅõÀÚ È®´ë·Î 2030³â±îÁö °ßÁ¶ÇÑ È®´ë°¡ ¿¹»óµË´Ï´Ù. ºÏ¹ÌÀÇ ¿ìÀ§¿Í ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±Þ¼ºÀåÀº ÀÌ Áö¿ªÀÇ Å« ¼ºÀå ±âȸ¸¦ µ¸º¸ÀÌ°Ô ÇÕ´Ï´Ù. Ç÷°üÁ¶¿µ°Ë»çÀÇ Ä§½À¼º µîÀÇ °úÁ¦´Â ȯÀÚÀÇ ÄèÀû¼º°ú Áø´Ü Á¤¹ÐµµÀÇ Çâ»óÀ» ¸ñÇ¥·Î ÇÑ ±â¼ú Çõ½Å¿¡ ÀÇÇØ ÇØ°áµÇ°í ÀÖÀ¸¸ç, ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ±â¼¼¸¦ È®½ÇÈ÷ Çϰí ÀÖ½À´Ï´Ù.
¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?
»ê¾÷°ú ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°ú ¿µÇâ, ½ÅÁ¦Ç° °³Ã´, °æÀïÀÇ ¿µÇâ
The Angioscope Device Market is expected to grow from USD 200.138 million in 2025 to USD 240.209 million in 2030, at a CAGR of 3.72%.
The global angioscope device market is experiencing significant growth, driven by the rising prevalence of cardiovascular diseases and an aging population. Angioscopes, used to examine the interior of blood vessels, enable direct visualization of vascular abnormalities, thrombus composition, and atherosclerosis staging. Unlike angiography, angioscopy is more invasive but provides critical insights for diagnosing and treating vascular diseases, particularly in cardiovascular care. The technology supports onsite bypass processes and informs optimal treatment strategies, enhancing patient outcomes.
Market Growth Drivers
The primary drivers include the increasing incidence of heart diseases, growing demand for minimally invasive procedures, and the rise in stent surgeries. The aging global population further amplifies the need for advanced diagnostic tools like angioscopes. Strategic collaborations among industry players are expanding product portfolios to meet the demand for non-invasive and patient-friendly solutions. For instance, partnerships between companies like ACIST Medical Systems, Inc. and Medis Medical Imaging are enhancing market reach and innovation in North America, driving adoption of angioscope technologies.
Market Segmentation Analysis
The angioscope device market is segmented by end-user and geography. By end-user, the market includes hospitals, ambulatory centers, and research facilities. Hospitals dominate due to increased investments in healthcare infrastructure and the growing need for advanced medical equipment to address cardiovascular diseases. The rise in hospital construction globally, supported by government initiatives to improve healthcare facilities, is boosting demand for angioscopes. Ambulatory centers are also gaining traction as minimally invasive procedures become more prevalent, while research facilities benefit from increased funding for vascular studies.
Technological Advancements and Research
Rising investments in research and development are propelling market growth. Ongoing advancements in angioscope technology are improving diagnostic accuracy and expanding applications. Increased expenditure on radiography and vascular research is driving demand for innovative angioscope devices, as researchers explore new ways to diagnose and manage cardiovascular conditions.
Geographical Outlook
North America is expected to hold a significant market share, driven by the high prevalence of cardiovascular diseases and robust healthcare infrastructure. Government initiatives, such as Canada's USD5 million investment in 2023 to support the Canadian Heart Function Alliance, aim to enhance heart failure diagnosis and treatment, further boosting demand for angioscopes. The Asia Pacific region is projected to experience rapid growth, fueled by increasing healthcare investments and rising cardiovascular disease rates in populous countries like China and India. Europe also shows strong potential, supported by advanced medical research and infrastructure development.
Market Outlook
The angioscope device market is poised for robust expansion through 2030, driven by technological advancements, strategic collaborations, and growing healthcare investments. North America's dominance and Asia Pacific's rapid growth highlight significant regional opportunities. Challenges, such as the invasive nature of angioscopy, are being addressed through innovations aimed at improving patient comfort and diagnostic precision, ensuring sustained market momentum.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Angioscope Device Market Segmentation: